Pharma Journalist -

GSK announced that the U.S. Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) for gepotidacin, an oral antibiotic, for the treatment of…
Read More...

Sartorius Stedim Biotech, a leading provider of solutions for the biopharmaceutical industry, has announced a new strategic partnership with Nanotein Technologies, a California-based…
Read More...

Arvinas, Inc., in partnership with Pfizer, announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for vepdegestrant, a novel oral…
Read More...

Ono Pharmaceutical Co., Ltd. announced that it has entered into a definitive agreement with Seikagaku Corporation to co-develop and exclusively market Gel-One, Seikagaku’s…
Read More...

CorMedix Inc. and Melinta Therapeutics LLC announced a definitive agreement for CorMedix to acquire Melinta. The selling shareholders will receive $300 million in total consideration at…
Read More...

Valneva SE announced that the U.S. Food and Drug Administration (FDA) has lifted its previously recommended pause on the use of the company’s Chikungunya vaccine, IXCHIQ, in individuals…
Read More...

Genmab A/S announced promising Phase 3 results from its EPCORE FL-1 clinical trial, which evaluated epcoritamab—a subcutaneous bispecific antibody—combined with rituximab and…
Read More...

Cingulate Inc., a biopharmaceutical company specializing in next-generation pharmaceutical products through its proprietary Precision Timed Release (PTR) technology, announced it has…
Read More...

Fresenius Kabi is expanding its biopharmaceutical portfolio through a new global licensing agreement with Polpharma Biologics S.A., securing exclusive rights to commercialize the…
Read More...

In a significant development for pediatric migraine care, Teva Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for AJOVY…
Read More...